Cancer’s ‘Dark Matter’ Outshines Neoantigens in Landmark Debate

A First-in-Class Cancer Vaccine Built From Human “Dark Genome” Just Beat Neoantigens In Scientific Showdown and Showed Improved Survival In Head & Neck Cancer

NAPLES, CAMPANIA, ITALY, December 10, 2025 /⁨EINPresswire.com⁩/ — UbiVac, a private …